LANDONI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 12.590
EU - Europa 5.475
AS - Asia 2.871
SA - Sud America 28
AF - Africa 18
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 12
Totale 21.009
Nazione #
US - Stati Uniti d'America 12.449
IT - Italia 1.398
SG - Singapore 1.132
IE - Irlanda 922
SE - Svezia 884
RU - Federazione Russa 734
CN - Cina 726
DE - Germania 586
HK - Hong Kong 497
UA - Ucraina 311
VN - Vietnam 240
GB - Regno Unito 190
FI - Finlandia 140
CA - Canada 128
ID - Indonesia 85
IN - India 70
FR - Francia 65
NL - Olanda 53
AT - Austria 38
DK - Danimarca 37
TR - Turchia 36
SK - Slovacchia (Repubblica Slovacca) 21
BE - Belgio 19
ES - Italia 18
IR - Iran 17
JP - Giappone 16
AU - Australia 13
CH - Svizzera 12
BR - Brasile 11
MX - Messico 10
PH - Filippine 10
RO - Romania 9
CL - Cile 8
CZ - Repubblica Ceca 8
EU - Europa 8
BG - Bulgaria 7
KR - Corea 6
TH - Thailandia 6
NP - Nepal 5
TW - Taiwan 5
MN - Mongolia 4
MU - Mauritius 4
PK - Pakistan 4
PL - Polonia 4
PT - Portogallo 4
RS - Serbia 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HR - Croazia 3
PE - Perù 3
SC - Seychelles 3
ZA - Sudafrica 3
AR - Argentina 2
BO - Bolivia 2
CO - Colombia 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MA - Marocco 2
MK - Macedonia 2
NG - Nigeria 2
VG - Isole Vergini Britanniche 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
GR - Grecia 1
IL - Israele 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PF - Polinesia Francese 1
SA - Arabia Saudita 1
Totale 21.009
Città #
Ann Arbor 2.071
Fairfield 1.397
Singapore 982
Woodbridge 964
Dublin 887
Houston 750
Ashburn 732
Wilmington 678
Chandler 636
Cambridge 500
Seattle 499
Santa Clara 493
Hong Kong 484
Princeton 442
New York 428
Frankfurt am Main 396
Milan 345
Jacksonville 288
Dearborn 277
Lawrence 197
Altamura 167
Boardman 126
Beijing 123
San Diego 117
Nanjing 101
Shanghai 91
Dong Ket 89
Helsinki 89
Andover 82
Jakarta 81
Guangzhou 65
Toronto 61
Rome 60
Fremont 59
London 58
Hamburg 45
Lachine 41
Vienna 37
Norwalk 33
Lissone 30
Falls Church 29
Nanchang 28
Shenyang 24
Bologna 23
Munich 23
Hebei 22
Chicago 21
Genova 21
Bratislava 20
Tianjin 20
Pune 19
Hangzhou 18
Monza 18
Brussels 17
Los Angeles 17
Ottawa 17
Brescia 16
Jinan 16
Shenzhen 16
Turin 16
Washington 15
Florence 14
Mountain View 14
Zhengzhou 13
Desio 11
Kunming 11
Adana 10
Carugate 10
Dallas 10
Huizen 10
Kilburn 10
Palermo 10
Changsha 9
Cinisello Balsamo 9
Jiaxing 9
Naples 9
Padova 9
Groningen 8
Lodi 8
Redmond 8
Sacramento 8
Sestri Levante 8
Amsterdam 7
Edmonton 7
Garbagnate Milanese 7
Hanoi 7
Hefei 7
Lappeenranta 7
Ludhiana 7
Menlo Park 7
Messina 7
Paris 7
Detroit 6
Hyderabad 6
Kiev 6
Laurel 6
Leawood 6
Manila 6
Moscow 6
New Bedfont 6
Totale 15.743
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 486
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 366
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 295
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 289
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 288
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 260
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 247
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 231
Erratum: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2017) 28 (iv72-iv83) DOI: 10.1093/annonc/mdx220) 229
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 214
Prevalence of Chlamydia trachomatis Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology 207
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 204
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 190
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 186
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 183
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 173
Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions 171
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 169
Uterine leiomyosarcoma: analysis of treatment failures and survival 167
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 164
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 164
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 153
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 150
Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy 149
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer 148
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study 147
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer 146
The clinical significance of the tumor marker CA-125 146
Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB 145
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 144
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 144
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 144
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 144
Chemo-conization in early cervical cancer 143
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 143
Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: A single institution prospective series 143
Endometrial stromal sarcoma: analysis of treatment failures and survival 136
European society of gynaecological oncology guidelines for the management of patients with Vulvar cancer 136
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 136
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 135
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 133
Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary 133
Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience 133
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer 133
Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series 132
Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients 131
Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer Center 130
The clinical implementation of primary HPV screening 130
Early oral versus "traditional" postoperative feeding in gynecologic oncology patients undergoing intestinal resection: A randomized controlled trial 129
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: Results of a multicenter retrospective Italian study 126
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 125
Fertility-Sparing Options in Young Women with Cervical Cancer 125
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 124
Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit 124
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 124
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture 122
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study 121
Teniposide in refractory ovarian cancer: a phase II study 119
Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a Major surgery: A randomized controlled trial 118
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience 117
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 117
Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy 116
Phase II study of the platinum analog TNO-6 in patients with advanced ovarian cancer 115
Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity 114
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 113
Repair of the Perineal Defect After Radical Vulvar Surgery: Direct Closure Versus Skin Flaps Reconstruction: A Retrospective Comparative Study 112
DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies 109
The prognostic relevance of histological type in uterine sarcomas: A cooperation task force (CTF) multivariate analysis of 249 cases 108
Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages 107
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 105
DNA interstrand cross-links induced by cis-dichlorodiammine platinum in ovarian cancer cells growing in primary culture 102
Borderline ovarian cancer 102
Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan 100
Effect of tamoxifen on steroid hormone receptors and creatine kinase activity in human endometrial carcinoma 100
The role of restaging borderline ovarian tumors: single institution experience and review of the literature 99
Surveillance procedures for patients with cervical carcinoma a review of the literature 99
Feasibility of transabdominal cardiophrenic lymphnode dissection in advanced ovarian cancer: Initial experience at a tertiary center 97
Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assay 97
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells 96
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 96
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 96
Poorly differentiated synovial sarcoma of the vagina: a case report and a clinical literature review 95
Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay 95
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 94
Robotic approach for cervical cancer: comparison with laparotomy: a case control study 94
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis 94
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM) 94
Mitozolomide activity on human cancer cells in vitro 93
Eviscerazione pelvica 92
Flow cytometric analysis of DNA content in human ovarian cancers 91
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin 89
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 89
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort 88
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer 88
Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update 85
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT) 85
How to address sexual problems in female cancer patients 84
Neoplasie dell’apparato genitale femminile 82
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 81
Guida clinica ai Marker Tumorali: CA 15-3 e CA-125 80
Totale 14.037
Categoria #
all - tutte 95.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.596 0 0 0 0 0 352 307 264 898 380 287 108
2020/20213.921 243 242 409 278 328 357 380 375 320 298 285 406
2021/20222.661 162 322 368 170 160 164 127 169 129 199 212 479
2022/20233.348 477 912 250 221 228 561 58 172 254 32 90 93
2023/20242.974 73 63 180 123 432 688 553 67 310 68 52 365
2024/20253.508 408 1.160 600 381 662 297 0 0 0 0 0 0
Totale 22.081